23.10.2015
- US protein engineering company Codexis has completed wave 1 of the transfer of its proprietary CodeEvolver platform technology to compatriot drug maker Merck. Under the agreement...
02.10.2014
- Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...
01.10.2014
- 3. Which new business models, like project-based or value-based outsourcing, could turn out to be the most promising guarantors for a successful cooperation with the pharmaceutical...
01.10.2014
- Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...
12.08.2014
- Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries headquartered in Redwood City, Calif./USA, has signed a platform technology license...
14.03.2014
- Codexis today announced the sale of its Hungarian subsidiary to Intrexon Corporation. The transaction closed on March 13, with a purchase price of US$ 1.5 million. No proprietary...
07.06.2012
- Codexis, a developer of industrial enzymes to enable the cost-advantaged production of biofuels, bio-based chemicals and pharmaceutical intermediates, announced the appointment of...
